Home / Kexing Biopharm...

Kexing Biopharm Product List-20251023

Article source：

Oct 22,2025

View： 1244

LABEL:

Related News

Great News! Reminton® Receives Approval for Its Seventh Indication in China for the Treatment of Ulcerative Colitis in Children Aged 6 Years and Older

Great News! Reminton® Receives Approval for Its Seventh Indication in China for the Treatment of Ulcerative Colitis in Children Aged 6 Years and Older

Beyond Horizons , Forward Together | Kexing Biopharm Concludes Participation in CPHI & PMEC China 2026

Beyond Horizons , Forward Together | Kexing Biopharm Concludes Participation in CPHI & PMEC China 2026

Kexing Biopharm’s Innovative Lupus Drug Completes First Participant Dosing in Phase I Clinical Trial

Kexing Biopharm’s Innovative Lupus Drug Completes First Participant Dosing in Phase I Clinical Trial

Kexing Biopharm's Albumin-Bound Paclitaxel Product Approved in Multiple Regions

Kexing Biopharm's Albumin-Bound Paclitaxel Product Approved in Multiple Regions

Kexing Biopharm and Sinotherapeutics Reach Cooperation Agreement to Expand Overseas Markets for FDA-Approved Tofacitinib Product

Kexing Biopharm and Sinotherapeutics Reach Cooperation Agreement to Expand Overseas Markets for FDA-Approved Tofacitinib Product

Kexing Biopharm’s GB18 project received clearance of IND application from NMPA and FDA

Kexing Biopharm’s GB18 project received clearance of IND application from NMPA and FDA